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C32 Podium Presentations
Aggrecanase did not appear to play a major role in regulating
aging-related degeneration in the soft tissues of the IVD, possibly
the result of a slower remodeling or lower aggrecan content for
these regions. Future studies of older mouse spines would be
useful to determine if these changes progress or stabilize with
aging-related degeneration.
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TRANSCRIPTIONAL INDUCTION OF TYPE X COLLAGEN
EXPRESSION AND HYPERTROPHIC DIFFERENTIATION
OF CHONDROCYTESBY RUNX2 DURING
OSTEOARTHRITIS PROGRESSION
A. Higashikawa, T. Saito, S. Kamekura, S. Ohba, T. Ikeda,
K. Nakamura, U-i. Chung, H. Kawaguchi
Sensory & Motor System Medicine, University of Tokyo, Tokyo,
Japan
Purpose: Hypertrophic differentiation of chondrocytes is essen-
tial not only for physiological skeletal development and growth,
but also for pathological disorders like osteoarthritis (OA). This
study investigated the molecular mechanism underlying tran-
scriptional regulation of type X collagen (COL10), the represen-
tative marker of hypertrophic differentiation, during OA progres-
sion.
Methods: We created an experimental mouse OA model by
producing instability in the knee joint through surgical resection
of the medial collateral ligament and meniscus. Expressions of
matrix proteins, proteinases, and transcription factors were then
examined by immunostainings and real-time RT-PCR in the me-
dial cartilage of knee joints during the progression of cartilage
degradation. To know the physiological role of a transcription
factor Runx2, we compared the OA progression in heterozygous
Runx2-deﬁcient mice and the wild-type littermates. We further
established stable lines of mouse chondrogenic ATDC5 cells
overexpressing Runx2 and dominant negative Runx2 through
retroviral transfection, and examined the differentiation by real-
time RT-PCR for COL10 mRNA level, and by Alizarin-red and
von Kossa stainings. Promoter activity of COL10 was deter-
mined by luciferase assays using HeLa cells transfected with
a luciferase-reporter gene construct containing a 4.5-kb frag-
ment of the human COL10 promoter. To conﬁrm the speciﬁc
binding of the identiﬁed core responsive region, we performed
electrophoretic mobility shift assay using nuclear extracts from
Runx2-overexpressed COS7 cells.
Results: Runx2 expression was induced in chondrocytes at the
superﬁcial and middle layers of joint cartilage as early as 2 weeks
after the knee joint instability, which was not observed in the
sham-operated joint. Most of the Runx2-positive chondrocytes
then expressed COL10 at 2-4 weeks, and thereafter produced
collagenases causing degradation of the cartilage matrix. In het-
erozygous Runx2-deﬁcient mice, however, COL10 expression,
as well as the subsequent collagenase expression and matrix
degradation, was suppressed under the OA induction, indicat-
ing that Runx2 contributes to the pathogenesis of OA through
chondrocyte hypertrophy. In the ATDC5 cell culture, COL10 ex-
pression, Alizarin-red and von Kossa stainings were markedly
increased by the Runx2 overexpression, whereas they were de-
creased by the dominant negative Runx2 overexpression. The
COL10 promoter activity was enhanced by Runx2 transfection,
and deletion analysis using a series of 5’-deletion constructs of
the promoter identiﬁed the core responsive element to Runx2
around the -80 bp region (HY-box). The transcriptional activity
of Runx2 was suppressed by a site-directed mutagenesis in
the HY-box. The tandem-repeat constructs responded to Runx2
depending on its repeat number. The wild-type HY-box oligonu-
cleotide probe, but not with the mutated probe, showed speciﬁc
binding with nuclear extracts from Runx2-overexpressed COS7
cells. Cold competition with an excess of unlabelled wild-type
probe, but not with the unlabelled mutated probe, suppressed
formation of the complex. In addition, the complex underwent
a supershift by the antibody to Runx2, conﬁrming the speciﬁc
binding of the HY-box and Runx2.
Conclusions: We demonstrated the contribution of Runx2 to
chondrocyte hypertrophy with COL10 induction during OA pro-
gression, and identiﬁed the core responsive region HY-box in
the human COL10 promoter. Studies on molecules related to
Runx2/HY-box will lead to elucidation of the molecular network
underlying chondrocyte hypertrophy and OA pathogenesis.
33
EXTREME OBESITY DUE TO IMPAIRED LEPTIN
SIGNALING DOES NOT CAUSE OSTEOARTHRITIS IN
MICE
T.M. Grifﬁn, J.L. Huebner, V.B. Kraus, F. Guilak
Duke University Medical Center, Durham, NC
Purpose: Osteoarthritis (OA) is strongly associated with obe-
sity. Both leptin deﬁcient (ob/ob) and leptin receptor deﬁcient
(db/db) mice develop morbid obesity, providing models in which
to explore the relationship between obesity and OA. However,
the pro-inﬂammatory effects of leptin and its association with OA
suggest that impairing leptin signaling may mitigate against joint
degeneration. We studied ob/ob, db/db, and wild-type (WT) mice
to determine whether leptin-impaired mice develop OA using
histological and microCT analysis. We also examined the effect
of leptin signaling on serum cytokine levels.
Methods: All analyses were performed on 44 wk-old female WT
(C57BL/6J; n=4), ob/ob (B6.V-Lepob/J; n=6), and db/db (B6.Cg-
m +/+ Leprdb/J; n=5) mice (Jackson Laboratories). Percent body
fat was determined by DEXA, and subchondral bone thickness,
and trabecular bone fraction and density of the tibial epiphysis
of the knees were determined by microCT. Sagittal histologi-
cal sections of knee joints were then scored using a modiﬁed
Mankin scoring system as follows: articular cartilage structure
(0-11), Safranin-O staining (0-8), tidemark duplication (0-3), ﬁ-
brocartilage (0-2), chondrocyte clones in uncalciﬁed cartilage
(0-2), hypertrophic chondrocytes (0-2), and relative subchondral
bone thickness (0-2) for a maximum score of 30 per location. 5
blinded graders scored sections separately for the medial and
lateral femoral condyles and tibial plateau. Levels of serum leptin
and hyaluronic acid (HA) were quantiﬁed by ELISA. The fol-
lowing serum cytokines and chemokines were measured using
a custom multiplex bead immunoassay (Biosource), speciﬁc to
mouse, with the Luminex 100 instrument: GM-CSF, IL-1α, IL-1β,
IL-6, IL-17, KC, RANTES, and TNF-α. A nested 2-level analysis
of variance (ANOVA) was used to determine statistical signiﬁ-
cance due to either impaired leptin signaling (pooled ob/ob and
db/db vs. WT) or strain (ob/ob vs. db/db).
Results: ob/ob and db/db mice had >3-fold increase in body
mass and >8-fold increase in body fat compared to WT mice
(p<0.01). Despite this extreme adiposity, mice with impaired
leptin signaling did not exhibit increased articular cartilage de-
generation. Mankin OA scores were not signiﬁcantly different for
the total joint (p=0.67) or for any of the joint locations (p>0.27).
ob/ob and db/db mice had signiﬁcantly reduced tibial (Fig. 1),
but not femoral (p=0.20), subchondral bone thickness. The re-
duced thickness was offset by an increased relative trabecular
bone fraction of the tibial epiphysis (Fig. 1), resulting in a similar
total epiphyseal bone volume (Fig. 1). Leptin levels were consis-
tent with expected phenotypes for the mice (Table 1). Cytokine,
chemokine, and HA levels were not signiﬁcantly affected by im-
paired leptin signaling, except for KC (analog to IL-8 in humans),
which was elevated in ob/ob and db/db mice (Table 1).
Conclusions: Despite becoming extremely obese with slightly
